Evidence map›Paper›PMID 29205493›Full record

ArticleJournal of veterinary internal medicine2018

Impact of Pretreatment Neutrophil Count on Chemotherapy Administration and Toxicity in Dogs with Lymphoma Treated with CHOP Chemotherapy.

Q Fournier, J-C Serra, I Handel, J Lawrence

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 20 citations in OpenAlex.

  1. Chemotherapy in a dog with neutropenia and marginal zone lymphoma.The Journal of veterinary medical science · 2026
    Article
  2. Article
  3. Assessment of neutrophil function in canine cancer patients undergoing chemotherapy and correlation with neutrophil numbers.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Q FournierRoyal (Dick) School of Veterinary Studies, Roslin Institute, The University of Edinburgh, Roslin, UK.ORCID http://orcid.org/0000-0003-3219-9459
J-C SerraRoyal (Dick) School of Veterinary Studies, Roslin Institute, The University of Edinburgh, Roslin, UK.
I HandelRoyal (Dick) School of Veterinary Studies, Roslin Institute, The University of Edinburgh, Roslin, UK.
J LawrenceRoyal (Dick) School of Veterinary Studies, Roslin Institute, The University of Edinburgh, Roslin, UK.
Roslin Institute · GBUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrechemotherapy absolute neutrophil count (ANC) cutoffs are arbitrary and vary across institutions and clinicians. Similarly, subjective guidelines are utilized for the administration of prophylactic antibiotics in neutropenic dogs.

objectivesTo evaluate the impact of various ANC cutoffs on chemotherapy administration in dogs with lymphoma treated with CHOP chemotherapy and to determine whether an association between prechemotherapy ANC and subsequent toxicity exists. The secondary objective was to evaluate a currently used ANC cutoff to indicate prescription of prophylactic antibiotics. ANIMALS: Dogs diagnosed with lymphoma treated with CHOP chemotherapy (n = 64).

methodsSix hundred and fifteen ANCs were stratified into 6 classes. The 3 ANC cutoffs 1.5 × 10

resultsChemotherapy was not administered in 7% of visits with an ANC cutoff of 1.5 × 10 CONCLUSION AND CLINICAL IMPORTANCE: The number of dose delays was minimized with a prechemotherapy ANC cutoff of 1.5 × 10

Indexed as

AnimalsAntibiotic ProphylaxisAntineoplastic Combined Chemotherapy ProtocolsBlood Cell CountChemotherapy-Induced Febrile NeutropeniaCyclophosphamideDog DiseasesDogsDoxorubicinFemaleLymphomaMaleNeutropeniaPrednisoloneVincristineCyclophosphamideDoxorubicinPrednisoloneVincristineAntimicrobialsChemotherapeuticsHematologyLymphomaOncology

Identifiers

PMID29205493
PMCPMC5787211
OpenAlexW2772249516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.